Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-15

Clinical Trial Update: CanGaroo® Registry Study

View source ↗

Summary

The CanGaroo Registry Study sponsored by Elutia Inc. related to cardiac arrhythmias has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CanGaroo Envelope

Snippet

Sponsor: Elutia Inc. | Conditions: Arrhythmias, Cardiac | Status: COMPLETED